Abstract

Protein activates small intestinal calcium sensing receptor (CaSR) and/or peptide transporter 1 (PepT1) to increase GLP-1, but the role in glucose and feeding regulation remains elusive. We performed intravenous glucose tolerance test and refeeding studies and infused 8% (w/v) casein hydrolysate into the upper small intestine (USI) or ileum of male rats. We found that USI casein vs. saline infusion increased glucose tolerance in chow (p<0.01) and HF-fed rats (p<0.05) and suppressed feeding in chow (p<0.01) but not HF rats. We inhibited CaSR via injecting lentivirus expressing shRNA of CaSR into the USI (reduced expression by ~40%) and CaSR knockdown negated casein to increase glucose tolerance but not to lower feeding (p<0.01). Instead, viral-mediated PepT1 knockdown by ~50% negated casein to lower feeding as similar to previously reported for glucose control. Thus, CaSR and PepT1 are required for casein in the USI to increase glucose tolerance, while PepT1 but not CaSR mediates casein to lower feeding, in chow rats. The differential role of PepT1 vs CaSR may explain why HF disrupts casein to regulate feeding but not glucose tolerance as HF inhibited PepT1 expression (p<0.05) but increased CaSR expression (p<0.05) in the USI. Ileal casein vs saline infusion increased glucose tolerance (p<0.01) and lowered feeding (p<0.01). Ileal CaSR inhibition negated casein vs saline to increase glucose tolerance and lower feeding, whereas ileal PepT1 inhibition failed to do so, indicating that ileal casein regulates glucose tolerance and food intake via PepT1-independent but CaSR-dependent pathways in chow rats. HF feeding inhibited ileal CaSR expression by ~60% (p<0.05) in association with a disruption in ileal casein action on feeding but surprisingly not on glucose control (p<0.01), suggesting that ileal casein could even regulate glucose tolerance independent of CaSR. In sum, we discover differential role of CaSR vs. PepT1 in the USI and ileum that alter feeding and glucose regulatory abilities of protein sensing. Disclosure D.Barros: None. R.J.W.Li: None. Y.Lim: None. S.Zhang: None. R.Kuah: None. A.Gao: None. T.K.Lam: None. Funding Canadian Institutes of Health Research (PJT183901)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.